Rad Roberts serves as Executive at Bellevue Life Sciences Acquisition Corp., where they oversee executive responsibilities. Since joining the company, Rad Roberts has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 14, 2023 involved receiving (via award) 20,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 14, 2023 | BLAC | $0 | Award | 20,000 | $N/A | Discretionary |
Rad Roberts currently holds 20,000 shares of Bellevue Life Sciences Acquisition Corp. (BLAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Rad Roberts has been a net neutral trader of BLAC stock. They have purchased $0 and sold $0 worth of shares.
Rad Roberts's most recent insider trade was on Feb 14, 2023, when they sold 20,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted